Risk factor
Modest price volatility
Profitability factor
Good growth
About
Inversiones La Construcción S.A. (ILC.SN) is a diversified enterprise with significant operations across both the financial and healthcare sectors, primarily in Chile and with a presence in Peru. The company's financial services encompass a range of offerings, including annuities, consumer lending specifically for pensioners, and various insurance products such as policies for retirees, individual life insurance, and credit life insurance. It also facilitates voluntary retirement savings. For its corporate clients, ILC provides a comprehensive suite of banking solutions. These include current accounts, credit lines, diverse financing options (some backed by state guarantees), foreign trade services, equipment leasing, factoring, investment management, and robust cash management and treasury services. Individual customers benefit from retail banking products like checking accounts, personal credit lines, insurance policies, mortgage loans, investment vehicles, and online fixed-term deposits. Furthermore, ILC offers group insurance schemes, including collective health and life insurance, along with collective credit life insurance specifically designed for mortgage products. Beyond direct product sales, the company also actively manages health insurance programs and retirement savings funds. In the healthcare domain, ILC maintains a substantial infrastructure, operating 42 outpatient clinics and hospitals, alongside 18 specialized oncology treatment centers. Founded in 1980, Inversiones La Construcción S.A. is headquartered in Santiago, Chile, and functions as a subsidiary of Cámara Chilena de La Construcción A.G.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of ILC.SN is 25000 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati